CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Personal financial planning is vital for achieving your financial goals. Learn about its importance and the process to get started.
28,655 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
The passing of kenyan tiktoker malon kiptarus at Dubai’s Jumeirah Beach shines a light on money matters for expats. T...
Gen Z is pushing a rebound in vinyl records and print media, shaping the market while stretching household budgets. T...
A high-profile fund sold a sizable GRAIL stake right before a dramatic 50% one-day drop. This article unpacks the mov...
FIFA President Gianni Infantino defended Mexico’s readiness as violence roils the country near the World Cup. This pi...
A big asset manager recently capped withdrawals from a private credit fund, shaking confidence in liquidity for inves...
When a senior leader at Black Stone Minerals sells a sizeable block of units, it can ripple through the stock. This a...
Hedge funds are chasing a single megacap, creating crowded trades. Learn what crowdedness means, how to read the sign...
A hypothetical SpaceX Nasdaq move could quietly lift required minimum distributions for retirees. This piece breaks d...
Open-source AI is drawing strong backing from investors and consumers alike. Hugging Face cofounder Thomas Wolf argue...
Clive Davis, the legendary talent scout who built Arista and launched icons like Whitney Houston, has died at age 94,...
Forward Industries jumped after confirming it expanded its SOL holdings by more than 500,000 coins. Here’s what this ...